FDA Warning Letter — DuPont Nutrition USA, Inc

Case 627211 — FEI 3013947845

The FDA took a Warning Letter action against DuPont Nutrition USA, Inc on Dec 2, 2022 (Newark, DE). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
DuPont Nutrition USA, Inc
Date
Dec 2, 2022
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
Newark, DE (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.